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Background: Staphylococcal protein A (spa) is an important virulence factor which enables Staphylococcus aureus
to evade host immune responses. Genotypes known as “spa-types”, based on highly variable Xr region sequences
of the spa-gene, are frequently used to classify strains. A weakness of current spa-typing primers is that
rearrangements in the IgG-binding region of the gene cause 1-2% of strains to be designated as “non-typeable”.
Results: We developed an improved primer which enabled sequencing of all strains, containing any type of
genetic rearrangement, in a large study among community carriers and hospital inpatients in Oxfordshire, UK (6110
isolates). We identified eight novel spa-gene variants, plus one previously described. Three of these rearrangements
would be designated “non-typeable” using current spa-typing methods; they occurred in 1.8% (72/3905)
asymptomatically carried and 0.6% (14/2205) inpatient S. aureus strains. Some individuals were simultaneously
colonized by both formerly non-typeable and typeable strains; previously such patients would have been identified
as carrying only currently typeable strains, underestimating mixed carriage prevalence and diversity. Formerly
non-typeable strains were found in more spa-types associated with multilocus sequence type ST398 (35%), common
among livestock, compared to other groups with any non-typeable strains (1-4%), suggesting particular spa-types
may have been under-represented in previous human studies.
Conclusions: This improved method allows us to spa-type previously non-typeable strains with rearrangements in
the spa-gene and to resolve cases of mixed colonization with deletions in one or more strains, thus accounting for
hidden diversity of S. aureus in both community and hospital environments.
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strainsBackground
Staphylococcus aureus is a commensal organism that
colonizes nasal mucosa in 25-30% of the healthy human
population [1-6] and is responsible for a wide range of
human diseases including serious nosocomial infections.
S. aureus encodes many virulence factors including the
surface Ig-binding protein A (spa) whose function is to
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article, unless otherwise stated.therefore prevent phagocytosis of the bacterial cells by
the host immune system [7-12].
Typing the highly variable Xr region of the spa-gene is
one of the most common methods for genotyping S.
aureus. Even if well-established genotyping methods like
MLST are indispensable, spa-typing has major advan-
tages due to its high discriminatory power, typing accuracy,
speed, reproducibility and ease of interpretation. Spa-typing
also facilitates communication and data comparison be-
tween national and international clinical laboratories [13].
However, one weakness of current spa-typing methods is
that rearrangements in the in the IgG-binding region of
the gene, where the forward spa-primer is located, lead totral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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spa-typeable S. aureus clinical strains with rearrangements
in the IgG-binding domain of the spa-gene were first de-
scribed by Baum et al. in 2009 [14]. Although artificially
constructed spa-deficient S. aureus strains are used in la-
boratory experiments [15-18], only a few other studies
have reported variants isolated from human and cattle
with rearrangements in the spa-gene [19-24]. Missing par-
ticular variants that cannot be typed may affect inferences
about genotype associations. Whilst the prevalence of such
rearrangements can be directly estimated from the pro-
portion of non-typeable strains, detecting rearrangements
that do not affect spa-typing would require sequencing
the whole spa-gene; nevertheless such rearrangements
may still be informative with respect to population
structure.
Further complexity is introduced by the fact that most
studies type only one colony per sample, thus assuming
S. aureus colonization is by a single strain and likely sys-
tematically underestimating the number of spa-types per
individual. The presence of non-typeable S. aureus strains
with rearrangements in the spa-gene increases the number
of undetected circulating spa-types even further.
Here we therefore developed a new set of primers
to amplify the spa-gene from all formerly non-typeable
S. aureus samples regardless of the specific spa-gene re-
arrangement. We used our modified spa-typing protocol
to investigate the nature and proportion of strains with
rearrangements in the S. aureus spa-gene in two large
studies of community nasal carriers and inpatients, and




Nasal swab samples were collected from consenting
individuals recruited from five General Practices (GP) in
Oxfordshire that were members of the Thames Valley
Primary Care Research Partnership, National Institute of
Health Research (approved by Oxfordshire Research
Ethics Committee B, reference 08/H0605/102, [25]). On
recruitment, a nasal swab was taken from each individ-
ual by a research nurse. Participants were trained in self-
swabbing and all participants who were culture-positive
for S. aureus (n = 360) on recruitment and one quarter
(n = 211) of initially culture-negative participants were
sent a self-swabbing kit after one month and then every
two months. Swabs in charcoal medium were returned
by mail and stored at 4°C before processing. During the
36 months of the study, S. aureus was isolated from at
least one swab of 442 individuals yielding 3905 samples
which were spa-typed and analyzed here.Inpatient samples
S. aureus isolates were obtained from samples collected
from the Intensive care Unit (ITU), Gerontology and
Trauma wards of the John Radcliffe hospital in Oxford
as a part of routine screening for inpatients for infection
control surveillance. For all three wards, nasal swabs
were collected from individuals at ward admission and
discharge as well as once a week during their stay within
the ward [26]. All swabs were taken by nurses, as de-
scribed above, and were processed by the routine la-
boratory at the John Radcliffe hospital, Oxford. In total,
S. aureus was isolated from 2205 samples from 1273 inpa-
tients (ITU: 1338 samples, 784 individuals; Gerontology:
134 samples, 72 individuals; Trauma: 733 samples, 417
individuals) which were spa-typed and analysed here.
Isolation of S. aureus and DNA extraction
Each nasal swab was placed in 5% NaCl enrichment
broth (E and O Laboratories) and incubated overnight at
37°C. A loopful of enrichment broth was sub-cultured
onto SaSelect chromogenic agar (Bio-Rad) and incubated at
37°C overnight. Pink/orange colonies regarded as S. aureus
were positively identified using a Prolex™ Staph Xtra
Latex Kit (Pro-Lab Diagnostics) and catalase, DNAse
and tube coagulase tests. Methicillin resistance was tested
on columbia agar with 5.0% salt (Oxoid) with BBL™
Sensi-Disc™ 1 μg Oxacillin discs (BD).
Mixed glycerol stocks of S. aureus cultures were pre-
pared by suspending several loopfuls of bacteria taken
by sweeping across the SaSelect plate in 1.5 ml of saline
(E and O Laboratories) with 200 μl of 45% glycerol for
storage at −80°C. Taking a sweep across the plate rather
than picking a single colony for glycerol stocks allowed
us to maintain the genetic diversity of nasal strains in
the sample for later analyses.
Crude S. aureus DNA extracts (‘boilates’) used for spa-
typing were made from mixed glycerol stocks revived on
SaSelect plates. Using a 1 mm loop, a small amount of
bacteria was emulsified into 60 μl of Tris-EDTA (TE)
buffer (Sigma-Aldrich), then heated in a thermocycler at
99.9°C for 10 minutes and centrifuged at 13,200 × g for
2 minutes. 40 μl of supernatant was removed without
disturbing the pellet and stored at −20°C for use as a
PCR template.
Spa-typing
A staged spa-typing protocol was developed to enable
identification of multiple-strain colonization on a large-
scale [27]. The polymorphic X region of the protein A
gene (spa) was amplified with primers 1095 F: 5′-AGAC
GATCCTTCGGTGAGC-3′ and 1517R: 5′-GCTTTTGC
AATGTCATTTACTG-3′ [28,29]. PCR reactions con-
sisted of 0.25 mM dNTPs (Qiagen), 0.5 U of GoTaq Flexi
DNA Polymerase (Promega), Colorless GoTaq Flexi
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primers in a volume of 10 μl. PCR conditions were 94°C
for 2 min; 35 cycles each of 94°C for 30 s, 50°C for 30 s,
and 72°C for 60 s; and a final extension at 72°C for
5 min. PCR products were purified using Agencourt
AMPure XP beads (Beckman Coulter).
Samples were sequenced with the same primers as
used in PCR. Sequencing reactions used BigDye v3.1 se-
quencing mix (Applied Biosystems) and were cycled using
30 cycles of 96°C for 10 s, 50°C for 5 s, and 60°C for
2 min. Products were purified with Agencourt CleanSEQ
beads (Beckman Coulter) and separated on an ABI 3730
DNA Analyzer (Applied Biosystems).
Chromatograms were analyzed using Ridom StaphType
v2.0.3 software (Ridom GmbH). The relationships between
spa-types were investigated using the BURP clustering
algorithm [30] incorporated into Ridom StaphType.
Identification of rearrangements in spa-gene
A small proportion of isolates did not yield clean sequence
traces with the original primers indicating the presence of
rearrangements in the spa-gene. To identify possible rear-
rangements, primers spa-3 F: 5′-ATAGCGTGATTTTG
CGGTT-3′ and spa-3R: 5′-CTAAATATAAATAATGTT
GTCACTTGGA-3′ [14] were used to amplify the whole
spa-gene. As some isolates failed to amplify even with this
extended set of primers, an alternate forward primer,
spaT3-F: 5′-CAACGCAATGGTTTCATCCA-3′ binding
upstream from 1095 F was used together with standard
reverse primer 1517R. Primer spaT3-F binds to a part of
sequence encoding an IgG-binding domain of the spa-
gene that is repeated five times in the gene (Figure 1). Due
to presence of multiple binding sites for the spaT3-F
primer within spa-gene, only the reverse primer (1517R)
was used for sequencing.
To identify rearrangements in the spa-gene which do
not affect standard spa-typing, a subset of 32 community
samples and 67 bacteraemia samples were sequenced withFigure 1 Scheme of the spa-gene with annealing sites for the novel spa
annealing sites for spaT3-F primer; grey arrow indicates annealing site for 109
standard primer; figures represent distance between the beginning of spaT3-F
D, A, B, C – IgG-binding domains, X – region which lacks IgG-binding activityboth spa-3 F/spa-3R and spaT3-F/1517R sets of primers.
67 bacteraemia samples were randomly selected from pre-
viously existed collection of hospital invasive isolates.
Sequences were analysed using ProSeq v3.2 (http://
dps.plants.ox.ac.uk/sequencing/proseq.htm).
Example sequences for each type of the spa-gene variant
have been deposited in the GenBank under the accession
numbers JX912490 to JX912498.
Statistical analyses
Fisher’s exact test, Chi square test and 5x2 exact test were
used to compare categorical variables between groups.
P values <0.05 were considered statistically significant.
Results and discussion
Identification of rearrangements in the spa-gene
Within two large longitudinal studies of S. aureus carriage
in the community (3905 isolates) [25] and hospital (2205
isolates) [26] several non-typeable S. aureus strains were
identified using standard spa-primers (1095 F/1517R) [14].
Isolates from both studies were spa-typed using a staged
protocol, developed to resolve single- and multiple-
strain colonization [27]. According to the protocol, spa-
sequences were classified as follows: (i) clean sequence
traces were interpreted as single strain colonisation,
(ii) mixed sequence traces, characterised by distinct
double peaks, were interpreted as putative multiple
strain colonization, and (iii) unreadable sequence traces
represented failed samples, which were retyped. Samples
with mixed sequence traces were further resolved by
isolating 12 individual colonies; if typing of individual
colonies failed, strains were considered non-typeable
with standard primers.
Sequence traces of non-typeable samples showed either
complete lack of amplification, or mixed sequence traces
from both DNA boilates of mixed glycerol stock and of
12 individual colonies. As previously shown [14], non-
typeability of S. aureus strains can be attributed toT3-F primer and standard primers. Notes: black arrows indicate five
5 F standard primer; white arrow indicates annealing site for 1517R
primer and the beginning of Xr region. Spa-gene: s – signal sequence, E,
and consists of repetitive region (Xr) and C-terminal region (Xc).
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cation in some of our samples. However the persistence
of mixed sequence traces that could not be resolved by
typing individual colonies indicated the presence of
other types of spa-gene rearrangements.
To identify the nature of rearrangements in all our
non-typeable strains we designed a new forward spaT3-F
primer and combined it with reverse primer 1517R, used
for routine spa-typing [29]. Primer spaT3-F has a bind-
ing site in each of the five IgG-binding domains of the
spa-gene upstream of the repetitive Xr region (Figure 1)
and resulted in up to five staged PCR products per sample,
depending on the type of rearrangements in the IgG-
binding region (Figure 2). Due to its multisite binding
within the spa-gene, the spaT3-F primer could be used
to type samples with deletions of up to four IgG-domains
of the spa-gene and to detect and type samples with mix-
tures of S. aureus strains with and without deletions.
With the novel spaT3-F/1517R primer set we were
able to type 100% of samples that could not be spa-
typed using the standard current set of primers (denoted
“formerly non-typeable”).Figure 2 Amplification of spa-locus with novel primers spaT3-F/1517R
control sample does not have any rearrangements in the spa-gene and sh
primer, including a faint band in the region of 500 bp. DelH shows one thi
spaT3-F annealing sites that had been brought close together by the delet
products due to insertion of additional spaT3-F annealing site. The rest of t
rearrangements (Figure 3). Amplification of these samples with the standar
with delE and delG, which affect the position of 1095 F standard primer. Fo
for the insC2) located at a variable position on the ladder depending on thIn total, we found eight completely novel deletions/in-
sertions in the IgG-binding region of the spa-gene plus
one deletion that has been reported before [14], in 6110
community and inpatient S. aureus strains from Oxford-
shire (Figure 3). We never observed the deletion of the
whole or a part of the repetitive Xr region in S. aureus,
in contrast to Baum at al who described partial or total
deletions of the Xr region in three bacteraemia isolates
[14]: our large study suggests this happens extremely
rarely in carriage. One explanation for the difference may
be that Baum et al. considered disease-causing isolates
while most of our community and hospital isolates were
carriage.
As expected, non-typeable samples that did not amplify
with the standard set of primers had one of two types of
deletions affecting the binding site for the original forward
primer. Deletion E (174 bp) was previously described by
Baum at al. in a clinical S. aureus strain [14]. Deletion G
(63 bp) is a novel deletion always paired with insertion B
(63 bp) (Figure 3). Non-typeable samples with persistent
mixed sequence traces revealed the presence of the in-
sertion C2 (174 bp) (Figure 3). This insertion containsfrom the samples with rearrangements in the spa-gene. A
ows five PCR bands according to five annealing sites of the spaT3-F
ck band most likely consisted of two merged bands from the two
ion. InsC2 has a bright band (600 bp) most likely consisted of two PCR
he samples display the number of bands according to the types of
d spa-typing primers 1095 F/1517R will give no bands for the samples
r the rest of the sample PCR will generate a single band (double band
e number of repeats within Xr region of each sample.
Figure 3 Scheme of the rearrangements identified in the IgG-binding domains of spa-gene in samples from Oxfordshire. Notes: The
insertions are indicated by grey rectangles. The deletions indicated by dotted thin lines. Black arrows indicate annealing sites for spaT3-F novel
primer; grey arrows indicates annealing site for 1095 F standard primer; white arrow indicates annealing site for 1517R standard primer. Grey
rectangles with arrows indicate insertions with additional binding sites for primers. Panel (a) indicates deletions found only in community
samples, panel (b) indicates deletions found only in inpatient samples and panel (c) indicates deletions found both in community and inpatient
samples. Spa gene: s – signal sequence, E, D, A, B, C sequences encoding IgG-binding domains, X - region which lacks IgG-binding activity and
consists of repetitive region (Xr) and C-terminal region (Xc). Asterisk indicates deletion previously described by Baum et al., 2009. Dagger indicates
deletions/insertions leading to strains being designated non-typeable using the standard primers.
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spa-forward primer, producing two PCR products and
distinct double peaks in sequence traces when sequenced
with the original spa-forward primer. Sequencing from
the reverse primer (1517R) produced clean sequence
traces without double peaks.
Surprisingly, in some samples that did not amplify with
the standard primer set we found rearrangements repre-
sented by deletion A (357 bp) and deletion D/insertion
A (174 bp/10 bp) that do not affect the position of the
standard forward primer. To investigate the presence of
deletions that do not affect spa-typing and therefore
can remain unnoticed, we sequenced the whole spa-
gene from 32 community carriage and 67 bacteraemia
isolates chosen at random from the previously spa-typed
collection. We found four novel deletions, deletion D
(174 bp) in both bacteraemia and community strains,
deletion L (183 bp) only in community strains, deletion
H (705 bp) and deletion I/insertion C1 (531 bp/ 174 bp)
only in bacteraemia isolates (Figure 3). The largest dele-
tions of three to four IgG-binding domains were found
only in S. aureus bacteraemia strains.
Therefore, the presence of different types of deletions
and insertions in the spa-gene, identified by spaT3-F/
1517R primers, demonstrates that S. aureus colonization/
infection is highly complex. People may have a single
strain without rearrangements, with deletions that do not
affect spa-typing, or with rearrangements that do affect
spa-typing. Alternatively, they may carry multiple strainswithout deletions in any strain, with ‘hidden’ deletions that
do not affect spa-typing in one or more strains, or with
rearrangements that do affect spa-typing in one or more
strains.
Prevalence of spa-gene rearrangements in community
and hospital strains
Spa-typing of 3905 community S. aureus isolates and 2205
hospital isolates using the staged spa-typing protocol
showed that 1.8% (n = 72) of samples from 1.8% commu-
nity carriers and 0.6% (n = 14) of samples from 0.7% inpa-
tients were formerly non-typeable (Table 1). Significantly
more strains from individuals in the community were
formerly non-typeable compared with hospital inpatients
(p < 0.0001), and there was also a trend towards more
individuals carrying formerly non-typeable strains in the
community than hospital (p = 0.053). One explanation
may be because more longitudinal samples were collected
per individual for the community compared with the in-
patient study (maximum 20 versus 4 samples respectively),
providing more opportunity to encounter non-typeable
strains in individuals in the community study.
The proportion of S. aureus strains with ‘hidden’ dele-
tions in the IgG-binging region of the spa-gene that do
not affect spa-typing was estimated using spaT3-F/
1517R primers on a random subset of previously typed
samples. These hidden spa-gene deletions were found
in 11% (6-19%) of S. aureus strains from 11% (6-19%) of
individuals (Table 2).
Table 1 S. aureus isolates with and without different types of rearrangement in the spa-gene in community and
inpatient samples: formerly non-typeable isolates
Group Community1 Hospital2
Isolates Individuals Isolates Individuals
no. % no. % no. % no. %
Total 3,905 100% 442 100% 2,205 100% 1,273 100%
Pure without deletions/insertions
or with hidden deletions3
3647 93.4% 334 75.6% 2055 93.2% 1150 90.3%
Mixed with or without deletions
and/or rearrangements4
258 6.6% 108 24.4% 150 6.8% 123 9.7%
Formerly non-typeable: i.e. pure
with rearrangements affecting
standard spa-typing
72 1.8% (from total) 8 1.8% (from total) 14 0.6% (from total) 9 0.7% (from total)
27.9% (from 12 picks) 7.4% (from12 picks) 9.3% (from 12 picks) 7.3% (from 12 picks)
1 – nasal swabs collected from individuals recruited in 5 GP practices in Oxfordshire.
2 – nasal swabs from individuals admitted to the adult ITU, Gerontology and Trauma wards of the Oxford University Hospitals NHS Trust.
3 – indicates where all samples from an individual were pure using our spa-typing protocol (i.e. were without deletions/insertions or only with hidden deletions)
versus any sample did not fall into this category.
4 –subjected to 12 single colony picks, i.e. 12 sub-colonies analysed from each sample.
Table 3 Spa-typing of S. aureus strains from a single
individual AE with two sets of primers: standard primers




DNA prep (mixed boilate) 12 single colony picks2
1095 F/1517R spaT3-F/1517R spaT3-F/1517R
AE-0 t230 MST1 t230/t012
AE-1 non-typable t012 t012
AE-2 t230 MST t230/t012
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point, be colonized with a strain that has deletions/
insertions in the IgG-binding region of the spa-gene,
2% carrying completely ‘non-typeable’ strains.
Spa-gene rearrangements lead mixed S. aureus
colonization in humans to be underestimated
The staged spa-typing protocol allowed us to detect the
simultaneous presence of two or more strains in 11% of
S. aureus carriers. However, the presence of deletions that
affect spa-typing in one or more strains within the mixture
complicates the typing process and leads to underestima-
tion of the prevalence of multiple colonization and num-
ber of strains involved.
The problem is illustrated using nine samples obtained
over 14 months from one community nasal carrier AE
(Table 3). Spa-typing with the standard primer sets
(1095 F/1517R) demonstrated that AE only ever carried
one strain, which was type t230 at most time points, the
spa-type t008 on one occasion and one non-typeable
strain. Re-typing the same DNA extractions with our
alternative novel primers (spaT3-F/1517R) showed that
all samples had mixed sequence traces, apart from the
formerly non-typeable strain that had deletion ETable 2 S. aureus isolates with and without different
types of rearrangement in the spa-gene in community
and inpatient samples: isolates with hidden deletions
Group Isolates Individuals
no. % no. %
Total strains without deletions/insertions or
with only hidden deletions investigated
99 100% 97 100%
Hidden deletions found 11 11% 11 11%
Note: Hidden deletions were found in 16% (5/32) of S. aureus strains from 16%
(5/31) individuals in the community and in 9% (6/67) strains from 9% (6/66)
hospital in patients with bacteraemia (p = 0.33); pooled data are therefore
presented.associated with spa-type t012. Therefore, 12 single col-
onies were isolated for each sample and re-typed with
alternative primers. This identified five spa-types car-
ried by AE at various time points, and mixed strain
colonization by two-three spa-types on four occasions,
including two strains with deletion E. We were unable
to resolve all samples by typing 12 individual colonies,
even though they showed presence of mixed sequence
traces (time points 4, 10, 12 and 14), which could be
explained by a low frequency of one of the colonizing
strains.
The limitations of the conventional spa-typing protocol
make it impossible to identify and type S. aureus strains
with rearrangements in the spa-gene in individuals withAE-4 t230 MST t230
AE-6 t230 MST t230/t528
AE-8 t008 MST t008/t012/t571
AE-10 t230 MST t230
AE-12 t230 MST t230
AE-14 t230 MST t230
1mixed sequence traces; 2spa-types in bold have delE and could not be typed
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col allows us to resolve cases of mixed strain colonization
with deletions in one or more strains. Even 12 single
colony picks could not always identify the presence of
low-frequency strains with deletions, illustrating the
even greater challenge of estimating the proportion of
non-typeable strains within mixed colonization. Thus
diversity in colonizing and infecting strains is inevitably
underestimated.
Inpatients’ strains can acquire deletions in the spa-gene
We also found that S. aureus strains can acquire deletions
in the spa-gene during inpatients’ hospital admission.
Such acquisition of deletions was never observed for lon-
gitudinal carriage strains from individuals in the commu-
nity, with those deletions observed being present from the
first time the strain carrying the deletion was identified
(Additional file 1: Table S1).
Among six hospital patients with deletions that affect
spa-typing, three individuals (BA, BB and BF) already
carried the strain with the deletion when they were admit-
ted. The three other patients (BC, BD and BE) acquired a
deletion during their hospital stay on the background of a
spa-type carried at admission (Table 4). There were eight,
four and six days between the last swab without and the
first swab with the acquired deletion for BC, BD and BE
respectively. All three patients acquiring deletions during
hospital admission either had long-term illnesses and/or
had taken several antibiotics (BC: teicoplanin; BD: doxy-
cycline; BD: flucloxacillin, penicillin, ciprofloxacin, vanco-
mycin, erythromycin, gentamicin, tetracycline).
The repetitive nature of the spa-gene makes it unstable
and highly prone to internal rearrangements, which inTable 4 Individuals who acquired a deletion in the S.
aureus spa-gene during their hospital admission
Individual ID Date swab
taken
Results Spa type Rearrangements
BC 30/01/2011 MSSA t298
BC 08/02/2011 MSSA t298 delG-insB
BD 14/04/2011 MSSA t571
BD 19/04/2011 MSSA t571 delG-insB
BD 26/04/2011 MSSA t571 delG-insB
BE-a1 20/06/2011 MSSA t179
BE-g2 20/06/2011 MSSA t179
BE-n3 20/06/2011 MSSA t179/t078
BE-th4 20/06/2011 MSSA t179/t078
BE 05/07/2011 MSSA t179/t078
BE 12/07/2011 MSSA t179/t078 delE
BE 20/07/2011 MSSA t179/t078 delE
1–4body sites swabs: a – axilla, g – groin, n – nose, th – throat; all other swabs
are nasal swabs; spa-types in bold acquired deletion that affects binding site
for standard forward spa-typing primer.bacteria occur via either RecA-dependent or RecA-
independent recombination [31-33]. These rearrange-
ments might have positive or negative effects as protein A
is an important virulence factor that plays a central role in
S. aureus defence against the host immune response.
There is new evidence that the antibiotic ciprofloxacin
increases the intrachromosomal DNA recombination rate
in Escherichia coli [34]. Other antibiotics might potentially
have similar effects, yet undiscovered. Taking into account
that the three inpatients who acquired deletions during
their stay at the hospital had been taking specific antibi-
otics for a long time or a wide range of antibiotics for a
short period, including ciprofloxacin, it is possible that
antibiotic pressure might be one factor that drives genetic
rearrangements in the S. aureus protein A gene. However,
we also cannot exclude the possibility that these deletions
may have been present already at low frequency, and un-
detected, before increasing to become the majority variant
(rather than being acquired de novo). Nevertheless this
scenario also would support antibiotics playing a role in
emergence of deletions to detectable levels.
In the community, most individuals colonized by S.
aureus strains carry them without displaying any symp-
toms. However, when some of them became invasive,
the change of habitat, for example on a background of
antibiotic pressure, might promote acquisition of rear-
rangements in the spa-gene that might be advantageous
in new environment even if they lead to loss or change
of protein function. As shown previously, progress of
infectious disease is typically associated with acquisition
of mutations or rearrangements in the pathogen, many of
which lead to loss of function in a number of genes [35].
Deletions appear to be over-represented in clonal line-
ages related to livestock
In total, we found 20 spa-types from 33 individuals asso-
ciated with nine types of rearrangements in the spa-gene
(Additional file 2: Table S2). All types of deletions were
associated with a mixture of related and unrelated spa-
types, only insertion C2 was associated with a group of 3
closely related spa-types: t021, t012 and t10173. The 20
spa-types with rearrangements were clustered into five
groups of closely-related variants and five non-related
singletons (Table 5).
Any clusters of related spa-types with a higher preva-
lence of rearrangements affecting spa-typing (delE,
delG-insB or insC2) would be likely to be underrepre-
sented, or even missing, in the majority of studies based
on routine spa-typing protocols. To test this hypothesis,
we compared the proportion of individuals with and
without rearrangements affecting spa-typing in the four
groups of spa-types and the singleton that we found had
one or more rearrangements affecting spa-typing (5 × 2
exact test, Table 5). In group 1 35% of strains were
Table 5 Spa-types and groups in which deletions/insertions in the spa-gene were observed


















Group 1 7 (21%) 7/20 (35%)*
t571 08–16–02–25–02–25–––––––34-25 6 (18%) delG-insB(5);
delE(1)
6/19 (32%)
t3085 08–16–02–25–02–25–34–25–34–25 1 (3%) delE (1) 1/1 (100%)
Group 2 9 (27%) 7/188 (4%)*
t021 15–12––––16–02–16––––––––––02–25–17–24––––––––– 4 (12%) delD(1) insC2(3) 3/57 (5%)
t298 15–12––––16–02–––––––––––––––––––17–24––––––––– 1 (3%) delG-insB (1) 1/5 (20%)
t10173 15–12–02–16–02––––25–17–25–02–25–17–24–24–––––– 1 (3%) insC2 (1) 1/1 (100%)
t012 15–12––––16–02–16––––––––––02–25–17–24–24–––––– 2 (6%) delE (1);
insC2 (1)
2/123 (2%)
t6803 15–12––––16–02–16––––––––––02–25–17–24–24–17–24 1 (3%) delD-insA (1) 0/2 (0%)
Group 3 3 (9%) -
t084 07–23–12–34–34–12–12–23–02–12–23 1 (3%) delH (1) -
t085 07–23–12–34–34–12––––23–02–12–23 2 (6%) delD (1); delA (1) -
Group 4 4 (12%) 3/74 (4%)*
t280 04–––––––––––20–17–12–12––17–––––––––––– 1 (3%) delG-insB (1) 1/4 (25%)
t227 04–––––––––––––––––12–12––17–––––––––––– 1 (3%) delD (1) 0/3 (0%)
t078 04–21a–12b–41c–20–17–12–12–17–––––––––––– 1 (3%) delE (1) 1/26 (4%)
t216 04–––––20–17––20–17–––––––––––31d–16e–34f 1 (3%) delG-insB (1) 1/41 (2%)
Group 5 3 (9%) 1/92 (1%)*
t032 26–23–23–13–23–31–29–17–31–29–17–25–17–25–16–28 2 (6%) delD (1) delE (1) 1/79 (1%)
t223 26–23––––13–23––––––––––––05g–17–25–17–25–16–28 1 (3%) delD (1) 0/13 (0%)
Singletons 7 (21%) -
t213 07–23–12–21–24–33–22–17 3 (9%) delD (3) -
t6792 08–16–02–16–17–13–17–13–17–16–34 1 (3%) delD (1) -
t6417 14–44–13–12–17–13–12–17–17–17–23–18 1 (3%) dell (1) -
t530 11–19–12–21–17–34–24–34–16 1 (3%) delE (1) 1/3 (33%)*
t7960 299–25–17–17–16–16–16–16 1 (3%) delI-insC1 (1) -
Total 33 (100%)
* P < 0.0001 comparing four groups of spa-types and the singleton with rearrangements affecting spa-typing (5 × 2 Fisher’s exact test).
21a repeat differing in one base from repeats 12 and 20.
12b repeat differing in two bases from repeats 20.
41c repeat differing in one base from repeat 17.
31d repeat differing in two bases from repeat 16.
16e repeat differing in one base from repeat 17.
34f repeat differing in two bases from repeats 12 and 20.
05g repeat differing in one base from repeat 29.
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proportion compared with the 1-4% in other groups or
the singleton t530 (p < 0.0001). Therefore, spa-type t571
and its closely related variants such as t3085 may well
be underrepresented in most S. aureus studies based on
spa-typing, as they could not be typed with the standard
set of primers when common deletions are present.
Interestingly, spa-type t571 belongs to clonal lineage
ST398 that contains MRSA and MSSA strains commonamong livestock. Spa-type t571 is closely related to type
t011 and t034, all most commonly associated with pigs
[36-40]. These spa-types have been found less com-
monly in dogs, cats and horses, and occasionally in cat-
tle and poultry [41,42]. Large-scale screening of pigs [36]
showed that 60% of them carried t034, 14% t1255 and
1.5% t571. Although ST398-associated spa-types have
been rarely found among the general human population,
they have been found more commonly in farmers
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owners are also more likely to carry these animal-related
types [43]. Recent studies have also reported the emer-
gence of livestock-associated MRSA clones of S. aureus
ST398 causing bacteraemias in humans, supporting
animal-independent transmission of such strains be-
tween humans [44,45].
It is unclear why ST398 S. aureus strains commonly
found in livestock frequently develop deletions in the
IgG-binding part of protein A gene after transmission to
humans. One possible explanation is that this might be a
part of S. aureus strain adaptation to a different immune
background where protein A plays a major role [7,8,12].
Another explanation might be that the livestock associated
strains have more rearrangements in the spa-gene prior
the transmission to humans due to high level of antibiotic
exposure in food-animal production [46-48]. Nevertheless,
our findings highlight the potential for these strains to
have been substantially under-represented in epidemio-
logical studies to date, and for strains formerly not-
typeable using standard methods to be a source of bias.
Conclusions
Spa-typing is a common technique used to classify
S. aureus strains in clinical practice (eg outbreak manage-
ment) and research. Rearrangements in the IgG-binding
region of the spa-gene make strains “non-typeable” with
commonly used primers. Using a novel primer, we typed
100% of samples and identified eight novel spa-gene
variants, plus one previously described; three of these
rearrangements cause strains to be designated as “non-
typeable” using current spa-typing methods.
Spa-typing of 6110 S. aureus isolates showed that 1.8%
of samples from 1.8% community carriers and 0.6% of
samples from 0.7% inpatients were formerly non-typeable.
We also found evidence of mixed colonization with strains
with and without gene rearrangements, and estimated that
up to 13% of carriers are colonized with “hidden” S. aureus
with deletions/insertions in the IgG-binding region at
some point. Using standard primers therefore underes-
timates spa-type diversity. We also found evidence of
inpatients acquiring spa-gene deletions de novo during
a hospital admission, suggesting that antibiotic pressure
might be one factor driving genetic rearrangements in
the S. aureus protein A gene. Finally, we found that
deletions formerly causing strains to be designated as
“non-typeable” were over-represented in clonal lineages
related to livestock, indicating that these may well be
have been underrepresented in most S. aureus studies.
This new improved spa-typing protocol therefore en-
ables previously overlooked S. aureus strains to be typed
and therefore contribute to our understanding of diver-
sity, carriage and transmission of S. aureus strains in
community and hospitals.Additional files
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